LanieLou _MAGADonian
@LanieLou_MAGADonian
23 December, 05:52
FDA Approves First Generic of Once-Daily GLP-1 Injection
to Lower Blood Sugar in Patients with Type 2 Diabetes =
FDA Pumping Out Injectables to as many
humans as possible to destroy their immune systems... w/ Vaids
https://www.fda.gov/news-e...
to Lower Blood Sugar in Patients with Type 2 Diabetes =
FDA Pumping Out Injectables to as many
humans as possible to destroy their immune systems... w/ Vaids
https://www.fda.gov/news-e...
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes | FDA
FDA approved the first generic referencing Victoza (liraglutide injection) 18 mg/3 mL, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes as an adjunct to diet and exercise.
https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-once-daily-glp-1-injection-lower-blood-sugar-patients-type-2-diabetesNotice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
I have has 1st hand experience with these drugs and this misleading....no lies...just misleading.....
06:02 PM - Dec 23, 2024
In response LanieLou _MAGADonian to her Publication
Only people mentioned by Robino in this post can reply
